Neurology
-
Randomized Controlled Trial Comparative Study Controlled Clinical Trial
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.
There is a paucity of therapies for gait impairment in Parkinson disease (PD). Open-label studies have suggested improved gait after treatment with methylphenidate (MPD). ⋯ NCT00526630.